|

Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information in Women

RECRUITINGN/ASponsored by University of Colorado, Denver
Actively Recruiting
PhaseN/A
SponsorUniversity of Colorado, Denver
Started2025-04-02
Est. completion2027-04-02
Eligibility
Age39 Years – 74 Years
SexFEMALE
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →

NCT06441474

Summary

The Understanding and Addressing Rejection of Personalized Cancer Risk Information study is a longitudinal study conducted to understand the nature of phenomenon of personalized cancer risk rejection in the context of mammography screening.

Eligibility

Age: 39 Years – 74 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

1. Female sex
2. Age 39-74 (i.e., people who are eligible for routine breast cancer screening and for whom guidelines recommend an informed, risk-based decision)
3. English literacy

Exclusion Criteria:

1\. Prior diagnosis of

1. breast cancer
2. Ductal carcinoma in situ (DCIS)
3. Lobular carcinoma in situ (LCIS)
4. Known BRCA1/2 gene mutation
5. Cowan syndrome
6. Li-Fraumeni syndrome
7. Having received previous chest radiation for treatment of Hodgkin's lymphoma.

Conditions3

Breast CancerBreast Cancer FemaleCancer

Locations2 sites

Colorado

1 site
University of Colorado Denver
Aurora, Colorado, 80045
Emily Vidal, MS303-724-5426emily.a.vidal@cuanschutz.edi

Missouri

1 site
Washington University in St. Louis
St Louis, Missouri, 63130
Erika Waters, PhD, MPH

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.